Pulmonary Hypertension Association Europe

11 November 2015

PHA Europe is the umbrella organization for national associations of patients living with pulmonary hypertension (PH) in Europe. It was founded in Vienna, Austria, in 2003 and is registered as an international non profit organization.

Over the years membership has grown steadily and currently stands at 33 patient associations patient organizations from 29 countries: Austria, Belgium (2), Bosnia & Herzegovina, Bulgaria (2), Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Israel, Ireland, Italy (2), Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Republic of Macedonia, Russia, Slovakia, Slovenia, Spain (ANHP), Sweden, Switzerland (2), Ukraine PHA, Turkey.

PHA Europe works together with its members to enhance awareness of PH across Europe, promote optimal standards of care for people living with the disease, ensure the availability of all approved treatments and encourage research for new medicines and therapies.

For general correspondence:
PHA EUROPE
European Pulmonary Hypertension Association
Wilhelmstraße 19
A-1120 Wien
Austria

For invoices:
PHA Europe
Am Lugeck 7
A-1010 Wien
Austria
VAT number: ATU68305327

Phone: (+ 43) 140 237 25
Mobile: (+ 43) 664 228 88 88
Fax: (+ 43) 140 935 28

This email address is being protected from spambots. You need JavaScript enabled to view it.
www.phaeurope.org

Dr Saleh Aldammas
Congress Chair
aldammas@hotmail.com
Saph.pht@gmail.com

Dr Abdulla Aldalaan
Congress Co-chair
aldalaan@hotmail.com
Saph.pht@gmail.com

Dr Hussam Sakkijha
Head, Executive committee
sakkijhahussamm@gmail.com
Saph.pht@gmail.com

Dr Hazem Hassan
Organizing Manager
hazem@globalaccess-eg.com

About SAPH

The Saudi Association for Pulmonary Hypertension (SAPH) is a medical and research national group of many medical specialists, who shared a common interest in the field of pulmonary vascular disease.

The Conference

Honorary Intl Members (PVRI)

Ghazwan Butrous, MD

Dr. Butrous is a professor of cardiopulmonary sciences at the University of Kent, Canterbury, UK. His major research interest in PVD is in the field of management of pulmonary vascular diseases, pulmonary vascular disease secondary to infectious diseases, signaling mechanisms, and remodeling of pulmonary vasculature. He is the secretary general of the pulmonary vascular research institute (PVRI).

H Ardeschir Ghofrani, MD

Professor Ghofrani is a senior physician at the University of Giessen lung center. He is the head of the divisions of pulmonary hypertension and intensive internal medicine. Dr. Ghofrani has developed new treatment concepts for patients with various disorders of pulmonary circulation. In 2002, Dr. Ghofrani was the recipient of the travel award of the ATS and the Francois Brenot Prize of the European Respiratory Society.

Paul Hassoun, MD

Paul M. Hassoun, MD, chairs the Assembly on Pulmonary Circulation, which consists of basic scientists and clinicians interested in the understanding of the vascular basis of lung disease—from the level of cell and molecular biology to translational biology and clinical medicine.